SCHEMBL7457326

SCHEMBL7457326

CCCCOC(=O)[C](C)C(=O)OC(C)CC

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.47
TSHR P16473 4/20 0.43
ATM Q13315 1/20 0.40
HPGD P15428 2/20 0.38
FAAH O00519 1/20 0.37
HCAR2 Q8TDS4 1/20 0.36
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NAAA Q02083 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
RAD52 P43351 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
MAPT P10636 1/20 0.34
LMNA P02545 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
EPHX1 P07099 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5872631 0.87 ALDH1A1 (0.47) ALDH1A1TSHRATMHPGDFAAH
SCHEMBL8709672 0.83 ALDH1A1 (0.65) ALDH1A1TSHRATMHPGDHCAR2
SCHEMBL6522815 0.79 ALDH1A1 (0.60) ALDH1A1TSHRATMHPGDHCAR2
Acetic Acid Butyl Ester SCHEMBL11469747 0.79 ALDH1A1 (0.67) ALDH1A1TSHRATMHPGDFAAH
SCHEMBL2988638 0.78 ALDH1A1 (0.48) ALDH1A1TSHRATMHPGDFAAH
SCHEMBL4924002 0.78 ALDH1A1 (0.48) ALDH1A1TSHRATMHPGDFAAH
SCHEMBL2976445 0.78 ALDH1A1 (0.48) ALDH1A1TSHRATMHPGDFAAH
Acetic Acid Butyl Ester SCHEMBL28080124 0.77 ALDH1A1 (0.64) ALDH1A1TSHRATMHPGDFAAH
Acetic Acid Butyl Ester SCHEMBL28080215 0.77 ALDH1A1 (0.64) ALDH1A1TSHRATMHPGDFAAH
Octane SCHEMBL28080256 0.76 ALDH1A1 (0.62) ALDH1A1TSHRATMFAAHNAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1244635-A2 4-ARYL-1-DIFLUOROMETHOXYIMIDAZOLE BASF AKTIENGESELLSCHAFT (DE) 2002-10-02 EP disclosed
EP-1165515-A1 PYRIDINE-2,3-DICARBOXYLIC ACID DIAMIDES BASF AKTIENGESELLSCHAFT (DE) 2002-01-02 EP disclosed
US-20010031865-A1 Substituted 3-phenyluracils KLINTZ RALF (DE) 2001-10-18 US disclosed
WO-2001049668-A2 4-ARYL-1-DIFLUOROMETHOXYIMIDAZOLES AND USE THEREOF AS HERBICIDES BASF AKTIENGESELLSCHAFT (DE) 2001-07-12 WO disclosed
US-6239074-B1 HERBICIDES, INSECTICIDES BASF AKTIENGESELLSCHAFT (DE) 2001-05-29 US disclosed
WO-2000058288-A1 PYRIDINE-2,3-DICARBOXYLIC ACID DIAMIDES BASF AKTIENGESELLSCHAFT (DE) 2000-10-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010031865-A1 Substituted 3-phenyluracils CCR1, CCR6, CCR3 ALDH1A1 1864/4885TSHR 1263/4885ATM 1300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.